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Jesu´s Mosquera, b Jose´ L. Mascaren˜as *a and Javier Montenegro *a
The cytosolic delivery of hydrophilic, anionic molecular probes and therapeutics is a major challenge in
chemical biology and medicine. Herein, we describe the design and synthesis of peptide–cage hybrids
that allow an efficient supramolecular binding, cell membrane translocation and cytosolic delivery of
a number of anionic dyes, including pyranine, carboxyfluorescein and several sulfonate-containing Alexa
dyes. This supramolecular caging strategy is successful in different cell lines, and the dynamic carrier
mechanism has been validated by U-tube experiments. The high efficiency of the reported approach
allowed intracellular pH tracking by exploiting the ratiometric excitation of the pyranine fluorescent probe.Introduction
Hydrophilic anionic small molecules and biopolymers are
highly valuable intracellular probes and therapeutics.1–5 This is
the case of important uorophores like uorescein and
sulfonated Alexas, or molecules like pyranine, a trisulfonated
pyrene that presents very appealing pH-sensitive uorescence.6,7
Unfortunately, these dyes cannot be efficiently transported
across cell membranes, mainly because of their negative charge
at physiological pH (Fig. 1a).6–12 Most strategies to promote the
intracellular uptake of small anionic molecules involve a tran-
sitory reduction of charge, usually by esterication of anionic
carboxylates or phosphates,1,4,12 but this requires a covalent
modication of the probe and the subsequent intracellular
cleavage of the appendage. Furthermore, in the case of the
sulfonated derivatives (Fig. 1a), which are very appealing from
the biophysical perspective,13 covalent esterication is synthet-
ically difficult and cannot be implemented in cell assays.14–16
Alternative delivery strategies involving electrostatic trap-
ping of the molecules within cationic amphiphiles have been
essentially limited to nucleic acid cargoes.17,18 Supramolecular
tactics3,19,20 and macrocyclic capsules such as cyclodextrins
and cucurbiturils have also been used as vehicles for cell
delivery of suitable guests,21 and uorescent probes.22–25
However, these approaches have been mainly used for trans-
porting hydrophobic molecules and present serious draw-
backs associated with the endosomal entrapment of themica Biolo´xica e Materiais Moleculares
ga´nica, Universidade de Santiago de
la, Spain. E-mail: joseluis.mascarenas@
14, Donostia/San Sebastia´n, Spain
(ESI) available: Detailed synthetic
039/c9sc02906k
8cargo.21,26 Cell-penetrating peptides have also been used for
uorophore delivery,24,25 but in most cases the cargo is cova-
lently linked to the peptide.27,28 Therefore, the cargo's nal
destination is intrinsically connected to the penetrating
peptide vehicle. Cytosolic anionic probe loading has also been
attempted by physical methods, such as microinjection,
strong hypotonic stress at high probe concentrations,29 or by
using pH or redox-responsive encapsulating vesicles.7,10,30
However these methods sometimes require specic technical
equipment and are limited to particular cell lines, and also
suffer from endosomal entrapment of the cargo. Current
strategies for the intracellular cytosolic delivery of anionicFig. 1 (a) Examples of important fluorescent probes that do not cross
cell membranes at low micromolar concentration. (b) This work:
a designed covalent hybrid between tetraarginine (blue spheres) and
a positively charged supramolecular cage is capable of delivering
planar anionic probes into living cells, and release them from
endosomes.
This journal is © The Royal Society of Chemistry 2019
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View Article Onlineuorescent probes are laborious, not practical and strongly
inefficient.
Therefore, there is a clear need for conceptually new meth-
odologies for the efficient cytosolic delivery of anionic probes.
Herein we present a solution to this challenge based on the
temporary encapsulation of these probes into positively charged
nitrogenated cages containing short cationic peptide pendants
(Fig. 1b). These supramolecular conjugates behave as “truck
and release” carriers and allow efficient cytosolic accumulation
of a variety of anionic uorescent cargoes that otherwise cannot
be internalized and released. We have also investigated the
transport mechanism and demonstrated an important appli-
cation of the strategy to track the intracellular pH by using the
ratiometric excitation of the pyranine probe.Results and discussion
The cage hybrids used in our study are inspired by the pio-
neering work of Nitschke and coworkers who synthesized a tris-
bipyridyl structure C that can trap pyraninemolecules with high
affinity in the aqueous environment (Fig. 2).31 Indeed, this host–
guest interaction has been successfully used as a switch to
control the cellular uptake of peptides32 and of gold nano-
particles previously decorated with pyranine moieties.33 There-
fore, we wondered whether supramolecular caging could be
used for the cellular transport and the cytosolic delivery of
planar anionic probes such as pyranine and/or sulfonated Alexa
dyes, owing to the charge neutralization that should occur upon
encapsulation.Fig. 2 (a) Cage-mediated cytosolic delivery: the peptide–cage vector re
the cargo into the cytosol of cells. In the cage/probe complex bipyridin
excitationmaxima can be used to track the intracellular pH (i.e. endosome
nM) with increasing concentrations of peptide–cage AcR4C, showing the
peptide–cage hybrid. Fitting of the fluorescence titration to a Hill mode
This journal is © The Royal Society of Chemistry 2019Intracellular delivery of pyranine
Initial experiments were carried out using different concentra-
tions of the cage C, in HeLa cells. No intracellular uorescence
was observed, which conrmed that this cationic host alone was
unable to promote the intracellular transport of pyranine (5 mM,
Fig. 3a and S3†). This is likely associated with the very poor
internalization ability of the cage alone.32
Therefore, we decided to covalently attach different posi-
tively charged peptide pendants to one of the vertices of this
cage in order to facilitate intracellular delivery (Fig. 2, S1 and
S2†). Tagging of the cage with peptide pendants was carried out
using standard conditions for amide bond formation, and the
peptide–cage vectors were puried and characterized by HPLC-
MS (one peptide per cage, see the ESI†). Attachment of octar-
ginine (R8) and medium-length amphiphilic peptides like A,
produced peptide–cage hybrids (TmR8C,
TmAC, superindex Tm
refers to peptides containing a TAMRA uorophore at the N-
terminus) that aggregated in the presence of pyranine, and
showed toxicity and membrane damage at 5 mM in HeLa cells
(Fig. S4†). The strongly cationic and amphiphilic character of
these cage hybrids could explain the higher toxicity in
comparison to their unmodied counterparts. However, modi-
cation of the cage C with tetraarginine (R4) afforded a peptide–
cage conjugate (R4C) with excellent aqueous solubility and cell
biocompatibility at 5 mM (Fig. S5†). HPLC-MS analysis
conrmed that the cage is attached to a single peptide (Fig. S23–
S26†).
We thus prepared two R4-cage hybrids to study the delivery of
pyranine: AcR4C and
TmR4C (super indexes: Ac for the acetylatedcognizes pyranine, promotes its membrane translocation, and releases
e has been substituted with a red line for clarity. The pH dependent
). (b) Structure of the peptide cage hybrids. (c) Titration of pyranine (8.4
decrease of fluorescence of the former with increasing amounts of the
l (KD ¼ 189 nM).
Chem. Sci., 2019, 10, 8930–8938 | 8931
Fig. 3 Transport experiments in cells. (a) Control experiments in HeLa cells showing confocal micrographs of cells incubated with pyranine (5
mM) and cage C (5 mM); nuclei stained with Hoechst (blue). (b) Top: confocal micrographs of HeLa cells incubated with both pyranine (5 mM,
green) and TmR4C (5 mM, red) for 30min in HKR buffer, and washedwith HKR buffer before imaging; nuclei stainedwith Hoechst (blue). The arrow
marks the nucleolar accumulation of the peptide–cage carrier. Bottom: confocal images and orthogonal projection of the same HeLa cells
showing TmR4C (red) and pyranine (green) cytosolic distribution and partial endosomal co-localization. (c) Transport of pyranine (15 mM, green) in
the presence of TmR4C (15 mM), after incubation for 30 min in Vero cells, in HKR. (d) Competition experiments (Vero cells, 30 min of incubation)
for AcR4C (10 mM) combined with pyranine (20 mM, green) in the presence of TAMRA (20 mM, red). (e) Transport experiments (HeLa) of pyranine (5
mM) with TmR4C (5 mM) after 30min, followed by several washes, and subsequent 30min incubation with 2 mMDAPI to checkmembrane integrity.
(d and e) Red (top) and blue (bottom) fluorescence channels for the TAMRA and DAPI respectively with pyranine (green in both cases). Arrows
indicate residual (red (top) and blue (bottom)) fluorescence. Insets show differential interference contrast (DIC) images. Excitation and emission
wavelengths: DAPI and Hoechst: lexc¼ 405 nm and lem¼ 450/50 nm; pyranine: lexc¼ 488 nm and lem¼ 525/50 nm; TAMRA: lexc¼ 561 nm and
lem ¼ 620/60 nm.
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View Article Onlinehybrid and Tm for the TAMRA labelled derivative, Fig. 2b and
S2†). Gratifyingly, titration experiments of the pyranine uo-
rophore with increasing concentrations of the peptide cage
hybrids (i.e. AcR4C), in phosphate buffer at pH 7, conrmed an
excellent host/guest supramolecular recognition of the probe by
the peptide–cage hybrids (Fig. 2c and S6a†).
The presence of the peptide reduced the affinity of pyranine
for the cage (189 nM vs. 1.2 nM of the cage alone),31 suggesting
that the cationic peptide might hinder the ability of the cage to
bind the anionic probe. The presence of the TAMRA moiety in
TmR4C further reduced the affinity (KD ¼ 12.6 mM). This obser-
vation suggests a potential steric effect in the labelled peptide or
a different supramolecular structure of the TAMRA labelled
peptide–cage hybrids, as we could not detect any interaction of
the cage with free TAMRA in uorescence titrations (Fig. S11d†).
Spinning disk confocal microscopy conrmed a very efficient
internalization of TmR4C at low concentrations (e.g. 5 mM,
Fig. S3d†) aer 30 min of incubation. The uorescence of the
peptide–cage hybrid alone was localized in punctate compart-
ments, the cytosol of the cell, and also accumulated in the
nucleolus (Fig. S3d and S7a†), as previously observed for other
arginine-rich peptides.34 Using this concentration of the
conjugate TmR4C (5 mM), we then carried out dose-response
transport experiments at increasing concentrations of pyr-
anine (Fig. S7†).8932 | Chem. Sci., 2019, 10, 8930–8938Not surprisingly, pyranine by itself or in the presence of the
cage alone is unable to enter cells at low micromolar concen-
trations (Fig. 3a and S3†); however, we were pleased to observe
that an equimolar (5 mM) co-incubation of pyranine and TmR4C
with HeLa cells leads to a homogeneous distribution of the
pyranine uorescence in the cell cytosol (Fig. 3b and S7†). We
could also detect a certain degree of endosomal co-localization
of the pyranine with the fraction of the peptide–cage hybrid that
remained in the endosomal compartments (Fig. 3b). The partial
co-localization and the dynamic supramolecular nature of the
carrier–cargo complex were in good agreement with the
proposedmechanism of carrier/cargo complexation, membrane
translocation and intracellular release. Therefore, the short
arginine tail and the cationic cage work synergistically to facil-
itate the loading and cellular transport of the anionic cargo.
Transport experiments at low temperature and in the pres-
ence of endocytic inhibitors showed a reduction of the uptake of
TmR4C, with or without pyranine, indicating the relevance of
energy dependent endocytosis for cell internalization (Fig. S8†).
However, as previously mentioned, diffuse uorescence of the
peptide–cage hybrid was observed in the cytosol and also
accumulated in the nucleolus of the cell (Fig. 3b and S7†).
Therefore, despite the presumable endocytic uptake mecha-
nism, the peptide–cage hybrid, with and without pyranine, was
able to reach, at least in part, the cytosol of the cell. As shown inThis journal is © The Royal Society of Chemistry 2019
Fig. 4 Transport experiments of several anionic dyes into Vero cells. (a) Emission wavelengths of the different fluorophores. (b to f) Chemical
structures and pseudocoloredmicrographs of Vero cells incubated for 30minwith the compounds indicated, diluted in HKR. (b) Pyranine (10 mM)
and TmR4C (10 mM). (c) CF (10 mM) and
TmR4C (10 mM). (d) Alexa Fluor 488 (20 mM) and
TmR4C (10 mM). (e) Alexa Fluor 546 (35 mM) and
AcR4C (15
mM). (f) Alexa Fluor 568 (25 mM) and AcR4C (15 mM). In all cases, control panels show the incubation of the cells with the same amount of dye in the
absence of the peptide–cage hybrid. Insets show DIC images. Excitation and emission wavelengths: pyranine, CF, and Alexa Fluor 488: lexc ¼
488 nm and lem ¼ 525/50 nm; Alexa Fluor 546 and Alexa Fluor 568: lexc ¼ 561 nm and lem ¼ 620/20 nm.
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View Article OnlineFig. 3c, the delivery strategy can be used with different cell lines
(e.g. Vero cells) with similar efficiency. The acetylated version of
the peptide–cage hybrid (AcR4C) also delivered the pyranine
probe into the cytosol of HeLa and Vero cells (Fig. S7e and S9c,
d†). Although the acetylated peptide could not be tracked by
microscopy, the similar uorescence patterns of the delivered
probe for the TAMRA labelled and the acetylated peptide–cage
hybrids suggest a similar internalization mechanism.
Cytotoxicity studies using MTT assays conrmed excellent
cell viability under the conditions employed in the transport
experiments (e.g. 5 mM peptide–cage and pyranine, Fig. S10†).
Higher concentrations of the peptide–cage hybrid (e.g. 20 mM)
in the absence of pyranine raised certain cytotoxicity, albeit this
toxicity was reduced when co-incubated with the anionic pyr-
anine cargo (Fig. S5 and S10†). This observation suggests that
decreasing the cationic character of the peptide–cage carrier by
supramolecular encapsulation of pyranine leads to more
biocompatible and less toxic derivatives (Fig. S10†). It is worth
noting that in all the above transport experiments the cell
membrane keeps its integrity, as further conrmed by subse-
quent treatment with DAPI and propidium iodide (Fig. 3e and
S9†). As expected, the cationic probe DAPI neither interacts norThis journal is © The Royal Society of Chemistry 2019is internalized by the peptide–cage hybrids. Also importantly,
control transport experiments using the tetra-arginine peptide
(TmR4) or the cage (C), instead of the hybrid, did not promote
any pyranine internalization (Fig. 3a and S3†).
Competition experiments by co-incubation of this acetylated
peptide–cage AcR4C (10 mM) with pyranine and TAMRA (20 mM
each), a uorophore that does not show interaction with the
cage at the concentrations tested (Fig. S11D†), conrmed the
exclusive cytosolic delivery of pyranine (green uorescence) but
not TAMRA (red uorescence) aer 30 min of simultaneous
incubation in the presence of both probes (Fig. 3d and S11†).
This result further conrms that the intracellular delivery of
pyranine by the peptide–cage hybrid is not due to an uncon-
trolled permeabilization of the plasma membrane and requires
selective interaction of the uorophore with the cage.Delivery of different anionic uorophores
The above-mentioned cellular transport also applies to other
planar/anionic uorescent probes such as carboxyuorescein
(CF, Fig. 4 and S12†), which is also encapsulated by the cage
(Fig. S13†). Importantly, we further validated the scope of the
approach by using three different sulfonate-containing AlexaChem. Sci., 2019, 10, 8930–8938 | 8933
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View Article OnlineFluor dyes, which exhibit different emission colours (lexc ¼ 488,
546 and 568 nm). While these uorophores are unable to enter
the cells alone, they are efficiently delivered into the cytosol of
the cells when the cage-peptide carrier was added to the milieu
(Fig. 4). In vitro titration assays conrmed that the probes also
bind to the peptide-containing cage (Fig. S14†).U-tube experiments
To obtain further information on the delivery mechanism, we
performed transport experiments in a U-tube, as this assay
unambiguously reports on the presence of molecular carriers
(Fig. 5).35,36 Briey, CHCl3 was placed at the bottom of the U-tube,
and two aqueous (cis and trans) buffers were deposited at both
sides of the tube. The peptide–cage transporter was then
combined with its cargo (pyranine) and with an anionic lipid (egg
yolk phosphatidylglycerol, EYPG) that acts as the physiological
counterion.35,36 In this type of assay, guanidinium-rich trans-
porters can dynamically exchange counterions to behave as
hydrophilic or hydrophobicmolecules in different environments.
Therefore, the mixture was then placed in the cis buffer, the
CHCl3 layer was carefully stirred, and aliquots of the trans buffer
were collected at different time points to quantify the potential
anion transference across the CHCl3 hydrophobic phase (see the
ESI†). These experiments conrmed the enhanced transference
of pyranine across the bulk phase in the presence of the peptide–
cage carrier (naked eye observation, Fig. 5a), compared to the
controls using only pyranine, the cage (C) or the tetraarginine
peptide (AcR4) (Fig. 5b and S15†).35 The strongly enhanced pyr-
anine transport of the peptide–cage hybrid (AcR4C) compared to
the acetylated peptide without a cage (AcR4) indicates that beyondFig. 5 U-tube transport experiments. (a) Pictures at time 0 and after
24 hours. (b) Transport of pyranine from the cis buffer (0.5 mL, AcR4C:
80 mM, EYPG: 10 mM and pyranine: 200 mM) into the trans buffer (0.5
mL) across the chloroform phase (1 mL) as a function of time. Buffer:
10 mM NamHnPO4, 100 mM NaCl, pH 7.4. Pyranine +
AcR4C (C),
pyranine + AcR4 (B), pyranine + C (,), pyranine ().
8934 | Chem. Sci., 2019, 10, 8930–8938electrostatics, the supramolecular interaction between the cage
and cargo is critical for the carrier mechanism (Fig. 5b).Live cell pH measurements
The regulation of intracellular pH is essential to maintain
cellular functions, and its alterations have been associated with
diseases.37 Therefore, diverse uorescent sensors for the
measurement of pH in different compartments of living cells
have been developed, from small molecules and pH-sensitive
uorescent proteins38 to more complex structures such as
nanocapsules39 or DNA nanomachines.40 However, the delivery
of these probes into the desired compartment is problematic,
which strongly hinders the required homogeneous intracellular
distribution of the probe. Pyranine has two pH-dependent
excitation maxima at 405 nm (protonated) and 450 nm (depro-
tonated)6 and might thus be used for intracellular ratiometric
pH tracking (Fig. 2a and 6), with a pKa that makes it especially
suitable for cytosolic pH measurements. Indeed, incubation of
Vero cells with TmR4C and pyranine (10 mM each, 30 min)
allowed the straightforward differentiation of the neutral
cytosol and the acidic organelles (Fig. 6b and c). Furthermore,
ratiometric analysis of intracellular pyranine, aer suitable pH
calibration in nigericin-clamped cells (Fig. S16 and S17†), vali-
dated the excellent ratiometric pH intracellular mapping with
spatiotemporal resolution (Fig. 6d). This method allowed the
precise discrimination of the neutral pH of cytosol (7.5), the
slightly acidic pH of the early endosomes (7.0) and the more
acidic pH of late endosomes (6.5).Fig. 6 Intracellular pH tracking in Vero cells. Confocal micrographs of
cells incubated with pyranine (10 mM) and TmR4C (10 mM) for 30 min in
HKR buffer. (a) DIC. (b) Channel (lexc ¼ 405 nm and lem ¼ 525/50 nm)
corresponding to the “protonated form” showing higher intensity in
the endosomes. (c) Channel (lexc ¼ 488 nm and lem ¼ 525/50 nm)
corresponding to the “deprotonated form” showing higher cytosolic
intensity. (d) Ratiometric images of Vero cells after cell calibration.
Arrows: purple (early endosomes) and yellow (late endosomes).
This journal is © The Royal Society of Chemistry 2019
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View Article OnlineConclusions
In summary, this work demonstrates that cationic cages
capable of hosting anionic dyes can be converted into highly
efficient cellular transporters of these otherwise non-
penetrating compounds, when the cages are covalently linked
to a tetraarginine peptide. The transport strategy, based on
a “truck and release” concept, can be operated in different cell
lines and for a palette of several planar anionic probes. The
efficient loading of the cell cytosol with pyranine could also be
used for ratiometric intracellular pH tracking. Our results pave
the way for the efficient delivery of hydrophilic therapeutics or
diagnosis probes.
Experimental
Synthesis of peptides
Peptides TmA, TmR8,
TmR4 and
AcR4 were synthesized according
to classic SPPS of peptides (Tm stands for tetramethylrhod-
amine, TAMRA), by manual Fmoc solid-phase peptide synthesis
on a 2-chlorotrityl chloride resin (1.14 mmol g1). The rst
coupling was performed in CH2Cl2 using DIEA as the base
whereas for the following couplings HBTU as the activator,
DIEA as the base, and DMF as solvent were used. The depro-
tection of the temporal Fmoc protecting group was performed
by treating the resin with 20% piperidine in DMF. Three
equivalents (0.15 mmol, 64.5 mg) of 5(6)-Carboxyte-
tramethylrhodamine (TAMRA) were coupled with 3 equivalents
of HATU and 5 equivalents of DIEA 0.2 M in DMF for 60 min.
Acetylation of the N-terminal group for the preparation of AcR4
was performed under standard Fmoc removal conditions (20%
piperidine in DMF) followed by treatment with a solution of
acetic anhydride and 2,6-lutidine (1 : 1, 1 mL) for 30 min. The
cleavage/deprotection step was performed by treatment of the
resin-bound peptide for 2 h with the following cleavage cocktail:
900 mL TFA, 50 mL CH2Cl2, 25 mL H2O and 25 mL TIS (1 mL of
cocktail/40 mg resin). Peptides were precipitated with Et2O and
puried by RP-HPLC. Additional details on synthesis and
characterization can be found in the ESI.†
Synthesis of peptide–cage hybrids
The cage C was prepared and puried following the procedure
reported in the literature.31,32 For the synthesis of the supra-
molecular conjugates, TmA, TmR8,
TmR4 and
AcR4 peptides were
dissolved in DMF (0.1 mM, 100 mL) before HATU (1 equiv.) and
DIEA (10 equiv.) were added to the solution. This solution was
added to a 0.1 mM solution of the cage C (1 equiv.) and the
reaction mixture was le stirring overnight. The resulting
mixture was puried by RP-HPLC and the peptide–cage species
was conrmed by mass spectrometry. Additional details on
synthesis and characterization can be found in the ESI.†
Fluorescence titrations
For the spectroscopic studies, a fresh solution of the dye in
phosphate buffer (10 mM, pH 7) was prepared and diluted into
a quartz Hellma® uorescence cuvette with a path-length of 14This journal is © The Royal Society of Chemistry 2019 10 mm (chamber volume 1.4 mL) to reduce the dye concen-
tration to the desired concentration in phosphate buffered
solution (pH 7). Measurements were performed using a Varian
Cary Eclipse uorometer using the following settings: incre-
ment, 1.0 nm; integration time, 0.2 s; excitation slit width,
5.0 nm; emission slit width, 20.0 nm. The uorescence emis-
sions of the titrations were plotted and tted using nonlinear
regression equations (Hill 1) to obtain the apparent KD for each
experiment. Data were tted using nonlinear analysis with
Origin 8.5 to the Hill 1 equation:
y ¼ ymax þ ðymin  ymaxÞ x
n
kn þ xn
where ymax and ymin are the maximal and minimal uorescence
values, x is the ratio of concentrations between the indicated
peptide and uorophore, n is the Hill coefficient and k is the
ratio of concentrations that correspond to the KD. From this
value, KD is calculated using the following equation:
KD ¼ kc
where k is the previously calculated ratio and c is the concen-
tration of the uorophore. A free value for the Hill coefficient (n)
was selected for most of the analysis, to account for the possi-
bility that more than one uorophore molecule interacts with
the cage.31 Fitting using a 1 : 1 model gave a similar KD value.
To 1.0 mL of 8.4 nM solution of pyranine, 40 nM solution of
carboxyuorescein (CF), 30 nM solution of TAMRA, 50 nM
solution of Alexa Fluor 488, 30 nM solution of Alexa Fluor 546,
or 50 nM solution of Alexa Fluor 568, in phosphate buffer
(10 mM, pH 7), aliquots of 19 mM stock solution of AcR4C were
sequentially added, and the uorescence spectrum was recor-
ded aer each addition. Emission measurements were carried
out by using an excitation wavelength of 415 nm for pyranine,
490 nm for CF, 488 nm for Alexa Fluor 488, and 520 nm for
TAMRA, Alexa Fluor 546 and Alexa Fluor 568. The emission
spectra were recorded at room temperature from 450 to 600 nm
for pyranine, from 495 to 700 nm for CF and Alexa Fluor 488,
and from 525 to 700 nm for TAMRA, Alexa Fluor 546 and Alexa
Fluor 568. The uorescence emission maxima of the titrations,
at 510 nm for pyranine, at 516 nm for CF, at 513 nm for Alexa
Fluor 488, at 570 nm for Alexa Fluor 546 and at 603 nm for Alexa
Fluor 568, were plotted and tted using nonlinear regression
equations (Hill 1) to achieve the apparent KD for each experi-
ment. For titrations with TmR4C, to a 60 nM solution of pyranine
or a 40 nM solution of CF, aliquots of 19 mM stock solution of
the peptide were sequentially added and the spectra were
recorded under the same conditions described for AcR4C.U-tube experiments
U-tube experiments were carried out following previously
described procedures35 with minimal modications. The cis
phase (0.46 mL; 0.200 mM pyranine, 10 mM NamHnPO4,
100 mM NaCl, pH 7.4) containing additional solution of EYPG
(10 mM) was vortexed with CHCl3 (0.5 mL). Then, 40 mL of
AcR4C, 40 mL of
AcR4 or 40 mL of C of a 1 mM aqueous solutionChem. Sci., 2019, 10, 8930–8938 | 8935
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View Article Onlinewere added, and the mixture was vortexed again. Both the
organic and aqueous layers were added carefully to the U-tube
containing CHCl3 (1 mL) and the trans phase (0.5 mL) from
the sampling side. The organic layer was stirred at 700 rpm at
room temperature. Aliquots (13.5 mL) were taken from the trans
phase as a function of time and diluted to 150 mL with a buffer
(10 mM NamHnPO4, 100 mM NaCl, pH 7.4). Measurements were
performed using a Varian Cary Eclipse uorometer with the
following settings: integration time, 0.2 s; excitation slit width,
5.0 nm; emission slit width, 20.0 nm; excitation wavelength,
460 nm. The emission spectra were recorded from 470 to
600 nm at 20 C.Cell lines and culture
HeLa (ATCC) and Vero (ATCC) cell lines were maintained at
37 C, 5% CO2, 95% humidity, in Dulbecco's Modied Eagle's
Medium (4500 mg L1 glucose, L-glutamine, sodium pyruvate
and sodium bicarbonate), supplemented with 10% fetal bovine
serum and 1% of Penicillin–Streptomycin–Glutamine mix, and
kept in an INCO108 incubator (Memmert).Cell transport experiments
HeLa or Vero cells seeded the day before on glass-bottom dishes
were washed with HEPES-Krebs-Ringer (HKR) buffer (5 mM
HEPES, 137 mM NaCl, 2.68 mM KCl, 2.05 mM MgCl2, 1.8 mM
CaCl2, pH 7.4) and incubated for 30 min with 1 mM Hoechst
33342 (ThermoFisher) in HKR to stain the nucleus. This solu-
tion was removed and cells were incubated for another 30 min
with pyranine (or other uorescent probes such as TAMRA, CF
or Alexa Fluor dyes) in combination with the peptide, cage or
peptide–cage hybrids at the concentrations indicated in the
legend of the gures. Aer this incubation time, cells were
washed twice with HKR and examined on the confocal micro-
scope. In some cases, the step of nuclear staining with Hoechst
was omitted. To check membrane integrity, aer incubation
with the complexes, cells were washed with HKR and further
incubated with 2 mM of DAPI diluted in HKR buffer for 30 min
or 0.5 mg mL1 of propidium iodide for 10 min, before washing
with HKR and imaging. To investigate the possibility of the in
situ capture of pyranine into the cage of the carrier, Vero cells
were incubated with 12.5 mMpyranine in HKR for 10 min before
adding dropwise a solution of AcR4C in HKR to a nal concen-
tration of both the peptide and pyranine of 10 mM and incu-
bated for 30 min at 37 C before imaging.In vitro pH measurements
To conrm pH sensitivity of the dye in the calibration buffers
used for in situ calibration (10 mMMES, 10 mM HEPES, 20 mM
glucose, 1 mM CaCl2, 1 mM MgCl2, 135 mM KCl, 20 mM NaCl;
pH adjusted with KOH), absorption spectra of pyranine in the
different buffers were obtained. Pyranine was diluted at 70 mM
in each buffer and absorbance between 330 and 510 nm was
measured using a Libra S60 spectrophotometer. Ratios between
absorbance at 450 and 405 nm were calculated and then
transformed using the following equation:8936 | Chem. Sci., 2019, 10, 8930–8938log10
 
Rmax  R
R Rmin
 
Abasic405 nm
Aacidic405 nm
!!
where R represents the ratio A450/A405, Rmax and Rmin are the
maximal and minimal ratio values, and Abasic405 and A
acidic
405 are the
absorbance of pyranine at the highest and lowest pH tested.
Data were tted to a linear model. The intercept (7.01) corre-
sponds to the pKa under these conditions.
pH studies of cells
For pH ratiometric measurements, Vero cells were incubated
with 10 mM pyranine and 10 mM TmR4C peptide for 30 min in
HKR buffer. The cells were then washed twice with HKR and
imaged. A control with no pyranine was also prepared to
quantify the background. To prepare a calibration curve, cells
were rst incubated with pyranine and TmR4C under standard
conditions (30 min, pH ¼ 7.4). Subsequently, the cells were
washed twice with high-potassium pH calibration buffers
(10 mM MES, 10 mM HEPES, 20 mM glucose, 1 mM CaCl2,
1 mMMgCl2, 135 mMKCl, 20mMNaCl; pH adjusted with KOH)
at each indicated pH. The cells were then incubated at the
corresponding pH for 20 min with the calibration buffers con-
taining 10 mg mL1 of the ionophore nigericin for pH clamping
before imaging. Images were acquired with a Zyla 4.2 PLUS
camera mounted on a Dragony spinning disk confocal
microscope (Andor), by excitation with 405 nm (protonated
form, PyrH) and 488 nm (deprotonated form, Pyr) lasers,
detecting the uorescence at 500–550 nm. Images from the
pyranine channels were processed with FIJI,41 as follows: the
background was subtracted from both channels and then the
image 488 was divided by the image 405. Mean values per eld
were obtained (Fig. S17b†) and data were linearized by loga-
rithmic conversion and adjusted to a linear model (Fig. S17c†).
The linear t was then used to assign estimated values of pH to
the images.
Flow cytometry
In order to further investigate the uptake mechanisms of the
supramolecular complex formed by TmR4C and pyranine, Vero
cells seeded the day before at 10.000 cells per well on a 96-well
plate were treated for 30 min with dynasore (80 mM) diluted in
DMEM without serum or antibiotics. The cells were then
washed with HKR and incubated with 15 mM TmR4C and 15 mM
pyranine during 30 min at 37 C with the same concentration of
the inhibitor in HKR buffer. For the incubation at low temper-
ature (4 C), the cells were placed on ice before the incubation,
and ice-cold solutions were used for the washes and incuba-
tions. Controls with 15 mM TmR4C alone and 15 mM pyranine
alone were also performed. Aer 30 min of incubation, the cells
were washed with HKR and trypsinized. Trypsin was neutralized
with 2% FBS in PBS with 5 mM EDTA and cell uorescence was
measured on a Guava EasyCyte™ cytometer using two lasers:
a blue laser (488 nm) with emission collected at 512/18 nm
(pyranine) and a green laser (532 nm) collecting the emission at
575/25 nm (TAMRA). Cells with typical FSC and SSC parameters
were selected and the median uorescence intensity (MFI) wasThis journal is © The Royal Society of Chemistry 2019
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View Article Onlinecalculated for each sample. Each condition was performed in
triplicate. Fluorescence values were normalized to the uptake of
each untreated control (100%) aer blank subtraction. In all
cases, data analysis was performed with InCyte soware
included in GuavaSo 3.2 (Millipore).Cell viability
Cell viability was measured by MTT assays. To evaluate the
toxicity of the treatment of cells with TmR4C,
AcR4C and pyr-
anine, Vero and HeLa cells were subjected to an MTT assay 1
hour and 24 h aer the incubation. One day before the assay,
a suspension of HeLa and Vero cells was plated in 96-well tissue
culture plates by adding 100 mL (10.000 cells) per well. Next
day, the medium was removed and the cells were incubated in
HKR in the presence of TmR4C,
AcR4C, and pyranine at different
concentrations (50 mL per well) during 1 hour of incubation at
37 C. Aer the incubation, HKR with the compounds was
removed and the pre-warmed DMEM containing 10% FBS was
added to the wells. To evaluate the toxicity at 1 hour, MTT (5 mg
mL1 in PBS, 10 mL per well) was added and the cells were
further incubated for 4 h. To evaluate the toxicity at 24 h, the
cells were incubated for 24 h before adding the MTT. The cells
were further incubated for 4 h in the presence of MTT. The
supernatant was carefully removed and the water-insoluble
formazan salt was dissolved in DMSO (100 mL per well). The
absorbance at 570 nmwasmeasured. Data points were collected
in triplicate and expressed as normalized values for untreated
control cells (100%) aer blank subtraction.Conflicts of interest
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